Tynorphin

Tynorphin is a synthetic opioid peptide which is a potent and competitive inhibitor of the enkephalinase class of enzymes which break down the endogenous enkephalin peptides.[1] It specifically inactivates dipeptidyl aminopeptidase III (DPP3) with very high efficacy, but also inhibits neutral endopeptidase (NEP), aminopeptidase N (APN), and angiotensin-converting enzyme (ACE) to a lesser extent.[1] It has a pentapeptide structure with the amino acid sequence Val-Val-Tyr-Pro-Trp.

Tynorphin
Clinical data
ATC code
  • None
Legal status
Legal status
  • In general: non-regulated
Identifiers
PubChem CID
ChemSpider
Chemical and physical data
FormulaC35H46N6O7
Molar mass662.8 g/mol g·mol−1
3D model (JSmol)

Tynorphin was discovered in an attempt to develop an enkephalinase inhibitor of greater potency than spinorphin.[1]

See also

References

  1. Yamamoto Y, Hashimoto J, Shimamura M, Yamaguchi T, Hazato T (April 2000). "Characterization of tynorphin, a potent endogenous inhibitor of dipeptidyl peptidaseIII". Peptides. 21 (4): 503–8. doi:10.1016/S0196-9781(00)00174-1. PMID 10822105.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.